Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation of the 2007 Annual Meeting of AHRQ

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Identifying CR Best Buy Drugs

Text Description is below the image.
  • Start with credible source of unbiased, rigorous analysis of clinical evidence about drug effectiveness (DERP)
  • Intense medical input through consultants, internal CU review, and medical peer review
  • Selections based on effectiveness, safety record, and price


2001 Legislation in Oregon was key: systematic reviews
Gradually grew into what we now call DERP, which includes 15 states (use for Medicaid drug selection) and 2 private members
Systematic reviews are done by AHRQ funded EPC's, including the EPC at OHSU, RAND, and UNC
We add price information
We have a process of intensive review, including medical peer review by outside experts

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care